Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Morris

Showing results (141-150 of 334) with videos related to

Pageof 34
Sort By:
Gene Therapy|April 30, 2010
A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancerM A Trujillo, M J Oneal, S McDonough, et al.
Annals of Neurology|July 1, 1988
Validation of clinical diagnostic criteria for Alzheimer's diseaseJ C Morris, D W McKeel, K Fulling, et al.
Archives of Neurology|April 1, 1993
Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and olderL Berg, D W McKeel, J P Miller, et al.
AJNR. American Journal of Neuroradiology|October 11, 2007
Neuropathology for the neuroradiologist: plaques and tanglesF J Wippold, N Cairns, K Vo, et al.
Neurology|December 13, 2000
Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's diseaseJ C Wang, J M Kwon, P Shah, et al.
Preparative Biochemistry|January 1, 1989
Capillary zone electrophoresis separation of recombinant human interleukin-3 and related proteinsR I Hecht, J C Morris, F S Stover, et al.
Lancet (London, England)|June 4, 1994
Protection against Alzheimer's disease with apoE epsilon 2C Talbot, C Lendon, N Craddock, et al.
Cancer Gene Therapy|October 6, 2012
A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancerM A Trujillo, M J Oneal, S McDonough, et al.
Neurology|March 1, 1990
Progressive aphasia: a precursor of global dementia?J Green, J C Morris, J Sandson, et al.
Neurology|April 11, 2007
American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competenceD Bacon, R S Fisher, J C Morris, et al.
Pageof 34

Showing results (141-150 of 334) with videos related to

Sort By:
Pageof 34
Gene Therapy|April 30, 2010
A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancerM A Trujillo, M J Oneal, S McDonough, et al.
Annals of Neurology|July 1, 1988
Validation of clinical diagnostic criteria for Alzheimer's diseaseJ C Morris, D W McKeel, K Fulling, et al.
Archives of Neurology|April 1, 1993
Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and olderL Berg, D W McKeel, J P Miller, et al.
AJNR. American Journal of Neuroradiology|October 11, 2007
Neuropathology for the neuroradiologist: plaques and tanglesF J Wippold, N Cairns, K Vo, et al.
Neurology|December 13, 2000
Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's diseaseJ C Wang, J M Kwon, P Shah, et al.
Preparative Biochemistry|January 1, 1989
Capillary zone electrophoresis separation of recombinant human interleukin-3 and related proteinsR I Hecht, J C Morris, F S Stover, et al.
Lancet (London, England)|June 4, 1994
Protection against Alzheimer's disease with apoE epsilon 2C Talbot, C Lendon, N Craddock, et al.
Cancer Gene Therapy|October 6, 2012
A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancerM A Trujillo, M J Oneal, S McDonough, et al.
Neurology|March 1, 1990
Progressive aphasia: a precursor of global dementia?J Green, J C Morris, J Sandson, et al.
Neurology|April 11, 2007
American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competenceD Bacon, R S Fisher, J C Morris, et al.
Pageof 34